410 related articles for article (PubMed ID: 32929830)
1. Assessing the impact of unmeasured confounders for credible and reliable real-world evidence.
Zhang X; Stamey JD; Mathur MB
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1219-1227. PubMed ID: 32929830
[TBL] [Abstract][Full Text] [Related]
2. Addressing unmeasured confounding in comparative observational research.
Zhang X; Faries DE; Li H; Stamey JD; Imbens GW
Pharmacoepidemiol Drug Saf; 2018 Apr; 27(4):373-382. PubMed ID: 29383840
[TBL] [Abstract][Full Text] [Related]
3. The impact of unmeasured within- and between-cluster confounding on the bias of effect estimatorsof a continuous exposure.
Li Y; Lee Y; Port FK; Robinson BM
Stat Methods Med Res; 2020 Aug; 29(8):2119-2139. PubMed ID: 31694489
[TBL] [Abstract][Full Text] [Related]
4. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study.
Fewell Z; Davey Smith G; Sterne JA
Am J Epidemiol; 2007 Sep; 166(6):646-55. PubMed ID: 17615092
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity analysis for the effects of multiple unmeasured confounders.
Groenwold RH; Sterne JA; Lawlor DA; Moons KG; Hoes AW; Tilling K
Ann Epidemiol; 2016 Sep; 26(9):605-11. PubMed ID: 27576907
[TBL] [Abstract][Full Text] [Related]
6. Bespoke Instruments: A new tool for addressing unmeasured confounders.
Richardson DB; Tchetgen Tchetgen EJ
Am J Epidemiol; 2022 Mar; 191(5):939-947. PubMed ID: 34907434
[TBL] [Abstract][Full Text] [Related]
7. Assessing the impact of unmeasured confounding for binary outcomes using confounding functions.
Kasza J; Wolfe R; Schuster T
Int J Epidemiol; 2017 Aug; 46(4):1303-1311. PubMed ID: 28338913
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity Analysis Without Assumptions.
Ding P; VanderWeele TJ
Epidemiology; 2016 May; 27(3):368-77. PubMed ID: 26841057
[TBL] [Abstract][Full Text] [Related]
9. How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies.
Barrowman MA; Peek N; Lambie M; Martin GP; Sperrin M
BMC Med Res Methodol; 2019 Jul; 19(1):166. PubMed ID: 31366331
[TBL] [Abstract][Full Text] [Related]
10. A comparison of methods to estimate the survivor average causal effect in the presence of missing data: a simulation study.
McGuinness MB; Kasza J; Karahalios A; Guymer RH; Finger RP; Simpson JA
BMC Med Res Methodol; 2019 Dec; 19(1):223. PubMed ID: 31795945
[TBL] [Abstract][Full Text] [Related]
11. A flexible, interpretable framework for assessing sensitivity to unmeasured confounding.
Dorie V; Harada M; Carnegie NB; Hill J
Stat Med; 2016 Sep; 35(20):3453-70. PubMed ID: 27139250
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity analyses of unmeasured and partially-measured confounders using multiple imputation in a vaccine safety study.
Xu S; Clarke CL; Newcomer SR; Daley MF; Glanz JM
Pharmacoepidemiol Drug Saf; 2021 Sep; 30(9):1200-1213. PubMed ID: 33988275
[TBL] [Abstract][Full Text] [Related]
13. Quantitative bias analysis in practice: review of software for regression with unmeasured confounding.
Kawabata E; Tilling K; Groenwold RHH; Hughes RA
BMC Med Res Methodol; 2023 May; 23(1):111. PubMed ID: 37142961
[TBL] [Abstract][Full Text] [Related]
14. Bayesian sensitivity analysis for unmeasured confounding in causal mediation analysis.
McCandless LC; Somers JM
Stat Methods Med Res; 2019 Feb; 28(2):515-531. PubMed ID: 28882092
[TBL] [Abstract][Full Text] [Related]
15. [Sensitivity analysis method for unmeasured confounding interference in observational study].
Wang DH; You DF; Huang LL; Zhao Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1470-1475. PubMed ID: 31838823
[No Abstract] [Full Text] [Related]
16. Adjustment for unmeasured confounding through informative priors for the confounder-outcome relation.
Groenwold RHH; Shofty I; Miočević M; van Smeden M; Klugkist I
BMC Med Res Methodol; 2018 Dec; 18(1):174. PubMed ID: 30577773
[TBL] [Abstract][Full Text] [Related]
17. Bias factor, maximum bias and the E-value: insight and extended applications.
Cusson A; Infante-Rivard C
Int J Epidemiol; 2020 Oct; 49(5):1509-1516. PubMed ID: 32995847
[TBL] [Abstract][Full Text] [Related]
18. "A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis".
Zhang X; Faries DE; Boytsov N; Stamey JD; Seaman JW
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):982-92. PubMed ID: 27396534
[TBL] [Abstract][Full Text] [Related]
19. Bayesian data fusion: Probabilistic sensitivity analysis for unmeasured confounding using informative priors based on secondary data.
Comment L; Coull BA; Zigler C; Valeri L
Biometrics; 2022 Jun; 78(2):730-741. PubMed ID: 33527348
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity analyses to estimate the potential impact of unmeasured confounding in causal research.
Groenwold RH; Nelson DB; Nichol KL; Hoes AW; Hak E
Int J Epidemiol; 2010 Feb; 39(1):107-17. PubMed ID: 19948779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
